Detalles de la búsqueda
1.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316325
2.
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.
Haematologica
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546698
3.
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica
; 107(9): 2064-2071, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142153
4.
Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.
Transfusion
; 62(8): 1602-1611, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35851959
5.
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
Ann Hematol
; 100(3): 779-787, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515310
6.
Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33808005
7.
Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis.
Ann Hematol
; 99(9): 2181-2190, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32715339
8.
Proton-sensing G protein-coupled receptors as regulators of cell proliferation and migration during tumor growth and wound healing.
Exp Dermatol
; 26(2): 127-132, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27623507
9.
Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions.
Eur J Immunol
; 45(9): 2504-16, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26114249
10.
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.
Front Oncol
; 13: 1177330, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37305564
11.
Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis.
Transplant Cell Ther
; 29(12): 772.e1-772.e10, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777112
12.
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis.
Transplant Cell Ther
; 29(12): 750-756, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709204
13.
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Nat Med
; 29(4): 906-916, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914893
14.
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.
Front Oncol
; 12: 852987, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35619924
15.
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy.
Cell Rep
; 29(1): 135-150.e9, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31577944
16.
Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells.
Front Pharmacol
; 9: 1258, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30450049
17.
Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinib.
Bone Marrow Transplant
; 54(5): 762-764, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30349038
Resultados
1 -
17
de 17
1
Próxima >
>>